Activity Provided By:

Paradigm Medical Communications, LLC.

Psoriasis Prime Time: The Role of TYK Inhibition in Psoriasis

Overview / Abstract:	Target Audience This activity has been designed to address the educational needs of dermatologists, dermatology nurse practitioners, and PAs. It may also be of benefit to primary care clinicians, rheumatologists, and other healthcare practitioners who are interested in the treatment of psoriasis. Program Overview In this edition of Psoriasis Prime Time, the faculty reviews the unique mechanism of action for allosteric tyrosine kinase 2 (TYK2) inhibitors compared with Janus kinase inhibitors, highlights the efficacy and safety data for the new TYK2 inhibitor in psoriasis, and uses a case-based discussion to illustrate how TYK2 inhibition can be incorporated into psoriasis treatment. Learning Objectives Upon completion of this activity, participants should be able to: Describe how allosteric inhibition of TYK2 confers efficacy and safety in psoriasis Outline the safety, efficacy, and role of TYK2 inhibition in psoriatic disease management Devise patient-centric, evidence-based treatment plans for patients with psoriasis
Expiration	Jun 19, 2025
Discipline(s)	Nurse Practitioner , Physician CME, Physician Assistant CME
Format	Online
Credits / Hours	0.5 AMA PRA Category 1 Credit(s)™
Accreditation	ACCME, ANCC
Presenters / Authors / Faculty	Faculty April W. Armstrong, MD, MPH April W. Armstrong, MD, MPH Professor and Chief of Dermatology University of California Los Angeles Los Angeles, CA Rishi P. Singh, MD Amit Garg, MD Professor and Founding Chair Department of Dermatology Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Professor, Center for Health Innovations and Outcomes Research Feinstein Institutes for Medical Research Hempstead, NY Mio Nakamura, MD, MS Mio Nakamura, MD, MS Assistant Professor Dermatology University of Michigan Ann Arbor, MI
Sponsors / Supporters / Grant Providers	Bristol Myers Squibb Company.
Keywords / Search Terms	Relias LLC Relias LLC., FreeCME., Psoriasis, TYK Inhibition Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map